ResMed, Inc. (NYSE:RMD)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

Recs

1
Player Avatar CelloSpice (80.81) Submitted: 3/4/2011 9:22:34 PM : Outperform Start Price: $30.87 RMD Score: +18.26

Because their strongest competitor, Respironics, has been bought by another company.

Featured Broker Partners


Advertisement